Vivos Therapeutics (VVOS) Q3 2023 Earnings

14NovConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-1.75
-1.2
-0.65
-0.1

Details

Expected EPS
-0.1
Actual EPS
-1.75
Surprise EPS
-1.65
Surprise Percent
+1,650%

Description

Vivos Therapeutics (VVOS) has reported earnings of -1.75 per share for Q3 2023.

0 Comments

Share your thoughts